Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alterome Therapeutics, Inc.

Clinical trials sponsored by Alterome Therapeutics, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New targeted drug shows promise for rare cancer mutation Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

New pill targets KRAS cancers in early human trial

Disease control Recruiting now

This early-phase trial tests an oral drug called ALTA3263 in about 448 adults with advanced solid tumors (like pancreatic, lung, or colorectal cancer) that have a KRAS mutation. The main goals are to check safety, find the right dose, and see how the body processes the drug. Part…

Phase 1 • Sponsor: Alterome Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:05 UTC